The regional concentration of tau- and Aβ deposits is however essential for a differential diagnosis of AD, especially among the different tauopathies (Hampel and Teipel, 2004; Gozes et al., 2009; Hampel et al., 2010). This evidence concerns the gene MAPT and Alzheimer disease.